期刊论文详细信息
Respiratory Research
Eligibility of real-life patients with COPD for inclusion in RCTs: a commentary
Commentary
Salvatore Battaglia1  Nicola Scichilone1 
[1] DIBIMIS, University of Palermo, Palermo, Italy;
关键词: Clinical trials;    COPD research;    Clinical practice;   
DOI  :  10.1186/s12931-016-0494-5
 received in 2016-10-27, accepted in 2016-12-15,  发布年份 2017
来源: Springer
PDF
【 摘 要 】

Randomized clinical trials (RCTs) are performed to provide evidence to support treatment decisions. Based on the nature of those studies and the need to avoid confounding factors, it has been argued that the population selected in RCTs only partially represents the real-life population. This assumption casts doubts on the applicability of the results provided by RCTs in the management of individuals with an established diagnosis of COPD, and advocates the need for complementary studies with a pragmatic design. Herein, we comment on the recent article published by Halpin and colleagues on the Journal [Halpin et al, Respir Res 17:120, 2016], in which higher rates of inclusions in RCTs for COPD are found compared to previous observations. By analyzing the design of the studies and the end results, we conclude that the accumulating evidence contribute to shed lights on how representative is the outpatient population of real life settings.

【 授权许可】

CC BY   
© The Author(s). 2017

【 预 览 】
附件列表
Files Size Format View
RO202311109581412ZK.pdf 347KB PDF download
【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  文献评价指标  
  下载次数:23次 浏览次数:2次